Roivant Sciences Ltd.ROIVNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank33
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-766.86M
Near historical average
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-750.50M
Historical baseline
PeriodValueYoY Change
TTM$-766.86M+9.1%
2024$-844.05M-10.1%
2023$-766.65M+10.4%
2022$-856.08M-23.1%
2021$-695.16M-24.6%
2020$-557.94M+27.2%
2019$-766.75M-